Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
News-Medical.Net on MSN

Redefining control and consistency in anaerobic microbiome workflows

Explore how smart automation enables precise, reproducible workflows in anaerobic microbiome research, improving accuracy and ...

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation ...

Genomic selection is a crucial tool for meeting future challenges in agriculture

Developing high-yielding, nutritious and climate-resilient crops is vital to safeguard the future of global food production.
Goldseiten

Kinross Gold Corp. reports strong 2025 third-quarter results

Kinross Gold announced its results for the third quarter ended Sept 30, 2025. This news release contains forward-looking information about expected future events and financial and operating ...